共 95 条
[1]
Ge D(2009)Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 399-401
[2]
Fellay J(2009)IL28B is associated with response to chronic hepatitis C interferon- alpha and ribavirin therapy Nat Genet 41 1100-1104
[3]
Thompson A(2009)Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 1105-1109
[4]
Simon J(2009)Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses J Leukoc Biol 86 23-32
[5]
Shianna K(2011)Interferon lambda: a new sword in cancer immunotherapy Clin Dev Immunol 2011 349575-498
[6]
Urban T(2012)Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C J Hepatol. 57 492-317
[7]
Suppiah V(2013)Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C Clin Gastroenterol Hepatol. 11 311-768
[8]
Moldovan M(2012)Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males Hepatology. 55 759-39
[9]
Ahlenstiel G(2004)Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C Comp Hepatol 3 8-412
[10]
Berg T(2008)FibroTest-ActiTest as a non-invasive marker of liver fibrosis Gastroenterol Clin Biol 32 22-391